Trial
NCT05009979
18F-DCFPyL PET/CT in Hepatocellular Carcinoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
National Cancer Institute (NCI)
Collaborators
—
Condition
Hepatocellular Carcinoma
Intervention
F18-FDG
Why stopped
Reason for termination was a combination of slow accrual in setting of austerity measures regarding resource allocation.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-28